FY2025 featured global expansion, new strategic alliances, and inclusion in WHO guidelines, but revenue declined 15.7% and net loss widened to $2.24 million. Material uncertainty exists regarding going concern due to recurring losses and low cash reserves.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.